Patents by Inventor Colin Skene

Colin Skene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Photodynamic Therapy and Diagnosis
    Publication number: 20230365577
    Abstract: The present invention relates to phyllochlorin analogues and their pharmaceutically acceptable salts, and compositions comprising phyllochlorin analogues and their pharmaceutically acceptable salts. Phyllochlorin analogues and pharmaceutically acceptable salts thereof are suitable for use in photodynamic therapy, cytoluminescent therapy and photodynamic diagnosis, for example, for treating or detecting a tumour, so or for antiviral treatment. The present invention also relates to the use of phyllochlorin analogues and pharmaceutically acceptable salts thereof in the manufacture of a phototherapeutic or photodiagnostic agent, and to a method of photodynamic therapy, cytoluminescent therapy or photodynamic diagnosis, for example, for treating or detecting a tumour, or for antiviral treatment.
    Type: Application
    Filed: May 18, 2023
    Publication date: November 16, 2023
    Inventors: Honsue Cho, Andrew N. Stephens, Sebastian M. Marcuccio, Christopher D. Donner, Kieran P. Stockton, Colin Skene, Jonathan Faber
  • Radioprotector compounds and methods
    Patent number: 8999993
    Abstract: The invention relates to novel compounds, processes for their preparation and their use in protecting biological materials from radiation damage (radioprotection).
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: April 7, 2015
    Assignee: Peter MacCallum Cancer Institute
    Inventors: Roger Francis Martin, Jonathan White, Pavel Lobachevsky, David Winkler, Colin Skene, Sebastian Marcuccio
  • RADIOPROTECTOR COMPOUNDS AND METHODS
    Publication number: 20130109678
    Abstract: The invention relates to novel compounds, processes for their preparation and their use in protecting biological materials from radiation damage (radioprotection).
    Type: Application
    Filed: April 6, 2011
    Publication date: May 2, 2013
    Applicant: PETER MACCALLUM CANCER INSTITUTE
    Inventors: Roger Francis Martin, Jonathan White, Pavel Lobachevsky, David Winkler, Colin Skene, Sebastian Maruccio
  • Novel methods for the treatment of inflammatory diseases
    Publication number: 20070010563
    Abstract: Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) are provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (I), either alone or as a part of combination therapy. Novel compounds of formula (I) are also provided for.
    Type: Application
    Filed: April 7, 2004
    Publication date: January 11, 2007
    Inventors: Eric Morand, Magdy Iskander, Colin Skene
  • Radioprotector compounds and methods
    Patent number: RE46943
    Abstract: The invention relates to novel compounds, processes for their preparation and their use in protecting biological materials from radiation damage (radioprotection).
    Type: Grant
    Filed: February 10, 2017
    Date of Patent: July 10, 2018
    Assignee: PETER MACCALLUM CANCER INSTITUTE
    Inventors: Roger Francis Martin, Jonathan White, Pavel Lobachevsky, David Winkler, Colin Skene, Sebastian Marcuccio